In the TCGA cohort of HNSCC, TET1, TET2 and TET3 mutations were identified in 9 of 510 patients (1.8%), 8 patients (1.6%) and 8 patients (1.6%), respectively [36]. The gene discussed is TET2; the disease is head and neck squamous cell carcinoma.